Clinical trials
Completed Phase 2/3 Recurrence trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 2 |
| 2006 | 1 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 1 |
| Celgene | 1 |
| Children's Oncology Group | 1 |
| ERYtech Pharma | 1 |
| Gustave Roussy, Cancer Campus, Grand Paris | 1 |
| Johns Hopkins University | 1 |
| London Health Sciences Centre | 1 |
| Nanfang Hospital, Southern Medical University | 1 |
| Seoul National University Hospital | 1 |
| Serum Institute of India Pvt. Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 16 |
| Neoplasms | 2 |
| Brain Neoplasms | 1 |
| Carcinoma, Squamous Cell | 1 |
| Demyelinating Diseases | 1 |
| Ependymoma | 1 |
| Graft vs Host Disease | 1 |
| Hematologic Neoplasms | 1 |
| Hodgkin Disease | 1 |
| Ischemic Attack, Transient | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.